Close Menu

This piece gets in on big-money merit. Check out the Wall Street Journal for a quick story about Novartis and MorphoSys, a German biotech, expanding their collaboration -- to the tune of a 10-year, $600 million partnership. The alliance is geared toward "the discovery and development of antibody-based biological drugs," according to the article.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.